Home > Drug Search >
  • Targets: Dopamine transporter (DAT)
  •   > 
Drug Filter
Category:
chemistry (39) biology (1)
Status:
Approved (8) Withdrawn (2) Phase Ⅲ (6) Phase Ⅱ (12) Phase Ⅰ (12)
Clinical Stage:
Pending (3) Active (12) Discontinued (15)
Company:
Sumitomo Dainippon (2) Genentech (1) GlaxoSmithKline (5) Jazz Pharmaceuticals (1) Merz Pharma (1) NeuroSearch (4) Novartis (2) Albany Molecular Research (1) Pfizer (1) Roche (1) Shire (2) SK biopharmaceuticals (3) Sunovion (3) Teva (1) Valeant (1) Unknown (4) Achillion Pharmaceutical (1) Euthymics Bioscience (4) AMMS (1) Laguna (1) Saniona (2) 3-V Biosciences (1) China Shijiazhuang Pharmaceutical Group/CSPC (1) Abbott (1) Abbvie (1) Bristol-Myers Squibb (2) Celgene (1)
Indication:
Anxiety (1) Atrial fibrillation (1) Attention deficit hyperactivity disorder (ADHD) (9) Depression (7) Erectile dysfunction (ED) (1) Excessive sleepiness (2) Major depressive disorder (MDD) (10) Narcolepsy (2) Neuropathic pain (2) Obesity (3) Parkinson's disease (PD) (2) Restless legs syndrome (3) Smoking cessation (1) Tuberculosis (1) Glomerulonephritis (1) Low back pain (1) Paroxysmal Nocturnal Hemoglobinuria (PNH) (1) Age-related macular degeneration (AMD) (1) Pain (1) Excessive daytime sleepiness (EDS) in narcolepsy (1) Alcoholism (1) Cocaine abuse (1) Metabolic Syndrome X (1) Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) (1) Central nervous system disorders (1) Stress urinary incontinence (SUI) (1) Bipolar depression (1)
Aprv. Year:
1997 (1) 2001 (1) 2007 (2)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top